Never fear, ohm20 is here...or at least one of his
Post# of 148158
From ohm20 regarding cenicriviroc
Quote:
Quote:
Aplaviroc, vicriviroc, INCB-9471 all down for the count. Maraviroc can't compete due to side effects. Cenicriviroc is our only competitor, being an allosteric, small molecule like maraviroc I think long term side effects will sideline it in favor of us except in CXCR5 HIV.
ohm20 should be classified as a human heart attack preventative drug...every time you find the next greatest therapeutic he finds a way to help you understand how leronlimab is better vis-a-vis science